Trials / Conditions / Precancerous/Nonmalignant Condition

Precancerous/Nonmalignant Condition

26 registered clinical trials studyying Precancerous/Nonmalignant Condition — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology) NCT07120945	Medtronic - MITG	N/A
Terminated	Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemi NCT00854581	University of Miami	Phase 4
No Longer Available	Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Inf NCT00547235	Fred Hutchinson Cancer Center	—
Completed	S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease NCT00898066	SWOG Cancer Research Network	—
Terminated	Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis NCT00524485	Roswell Park Cancer Institute	N/A
Terminated	Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia NCT00118066	Rutgers, The State University of New Jersey	Phase 2
Terminated	T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients W NCT00589602	The Cleveland Clinic	Phase 2
Completed	Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer NCT00070382	Jonsson Comprehensive Cancer Center	Phase 3
Completed	Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Dis NCT00453336	University of Miami	Phase 2
Completed	Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia NCT00064194	NCIC Clinical Trials Group	Phase 3
Active Not Recruiting	Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders NCT00544115	City of Hope Medical Center	Phase 2
Completed	Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Kera NCT00021294	University of Arizona	Phase 2
Completed	Non-Ablative Allo HSCT For Hematologic Malignancies or SAA NCT00006379	Case Comprehensive Cancer Center	Phase 2
Completed	Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter NCT00006083	Jonsson Comprehensive Cancer Center	Phase 3
Completed	S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate NCT00030901	SWOG Cancer Research Network	Phase 3
Completed	EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer NCT00004258	Indiana University School of Medicine	Phase 1
Completed	Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer NCT00004232	Northwestern University	Phase 1
Completed	Bone Marrow Transplantation in Treating Patients With Hematologic Cancer NCT00005804	Fred Hutchinson Cancer Center	Phase 2
Completed	Stem Cell Transplantation in Treating Patients With Hematologic Cancer NCT00004904	Northwestern University	Phase 1
Completed	UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia NCT00003598	University of Michigan Rogel Cancer Center	N/A
Terminated	12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder NCT00004058	University of Medicine and Dentistry of New Jersey	Phase 1
Completed	Treatment for Chronic Pain in Patients With Advanced Cancer NCT00003687	NCIC Clinical Trials Group	Phase 3
Completed	Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer NCT00003082	University of Arizona	Phase 1
Completed	Cytomegalovirus Vaccine in Healthy Participants NCT00712634	City of Hope Medical Center	Phase 1
Completed	Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory NCT00003406	Cancer Treatment Centers of America	Phase 1 / Phase 2
Completed	Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer NCT00002504	Hoag Memorial Hospital Presbyterian	Phase 2